Advaxis to close AIM2CERV trial, focus resources on neoantigen-directed immunotherapies June 28, 2019
Phase I/II LuPIN trial of [177Lu]PSMA-617 and NOX-66 in men with mCRPC shows early signs of efficacy June 28, 2019
LSK BioPharma reports topline data from phase III study of rivoceranib in advanced gastric cancer June 28, 2019
RSS